12.32 USD
+0.08 (+0.65%)
12.3291 USD
+0.01 (+0.07%)
Overall VTRS gets a fundamental rating of 4 out of 10. We evaluated VTRS against 192 industry peers in the Pharmaceuticals industry. While VTRS is still in line with the averages on profitability rating, there are concerns on its financial health. VTRS is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year VTRS was profitable.
VTRS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VTRS reported negative net income in multiple years.
In the past 5 years VTRS always reported a positive cash flow from operatings.
1.2 Ratios
VTRS has a better Return On Assets (-9.73%) than 67.19% of its industry peers.
VTRS's Return On Equity of -24.26% is fine compared to the rest of the industry. VTRS outperforms 64.58% of its industry peers.
VTRS has a Return On Invested Capital of 3.41%. This is amongst the best in the industry. VTRS outperforms 80.73% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VTRS is significantly below the industry average of 12.85%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.73% | ||
| ROE | -24.26% | ||
| ROIC | 3.41% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
1.3 Margins
VTRS has a Operating Margin of 9.34%. This is amongst the best in the industry. VTRS outperforms 82.29% of its industry peers.
In the last couple of years the Operating Margin of VTRS has declined.
The Gross Margin of VTRS (39.36%) is better than 60.94% of its industry peers.
In the last couple of years the Gross Margin of VTRS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.34% | ||
| PM (TTM) | N/A | ||
| GM | 39.36% |
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VTRS is destroying value.
Compared to 1 year ago, VTRS has less shares outstanding
Compared to 5 years ago, VTRS has more shares outstanding
The debt/assets ratio for VTRS has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.94, we must say that VTRS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.94, VTRS perfoms like the industry average, outperforming 51.04% of the companies in the same industry.
VTRS has a debt to FCF ratio of 8.96. This is a slightly negative value and a sign of low solvency as VTRS would need 8.96 years to pay back of all of its debts.
The Debt to FCF ratio of VTRS (8.96) is better than 79.69% of its industry peers.
A Debt/Equity ratio of 0.82 indicates that VTRS is somewhat dependend on debt financing.
The Debt to Equity ratio of VTRS (0.82) is worse than 71.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 8.96 | ||
| Altman-Z | 0.94 |
ROIC/WACC0.42
WACC8.05%
2.3 Liquidity
A Current Ratio of 1.35 indicates that VTRS should not have too much problems paying its short term obligations.
VTRS has a Current ratio of 1.35. This is in the lower half of the industry: VTRS underperforms 74.48% of its industry peers.
A Quick Ratio of 0.79 indicates that VTRS may have some problems paying its short term obligations.
With a Quick ratio value of 0.79, VTRS is not doing good in the industry: 82.81% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The earnings per share for VTRS have decreased strongly by -14.65% in the last year.
The Earnings Per Share has been decreasing by -9.73% on average over the past years.
VTRS shows a decrease in Revenue. In the last year, the revenue decreased by -6.14%.
The Revenue has been growing slightly by 5.09% on average over the past years.
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
3.2 Future
VTRS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.45% yearly.
VTRS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.49% yearly.
EPS Next Y-10.83%
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
EPS Next 5Y4.45%
Revenue Next Year-4.74%
Revenue Next 2Y-1.84%
Revenue Next 3Y-0.59%
Revenue Next 5Y0.49%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 5.29, which indicates a rather cheap valuation of VTRS.
Based on the Price/Earnings ratio, VTRS is valued cheaper than 96.35% of the companies in the same industry.
VTRS is valuated cheaply when we compare the Price/Earnings ratio to 26.57, which is the current average of the S&P500 Index.
VTRS is valuated cheaply with a Price/Forward Earnings ratio of 4.89.
Based on the Price/Forward Earnings ratio, VTRS is valued cheaper than 95.83% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, VTRS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.29 | ||
| Fwd PE | 4.89 |
4.2 Price Multiples
95.83% of the companies in the same industry are more expensive than VTRS, based on the Enterprise Value to EBITDA ratio.
VTRS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VTRS is cheaper than 92.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.81 | ||
| EV/EBITDA | 6.68 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
5. Dividend
5.1 Amount
VTRS has a Yearly Dividend Yield of 3.92%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 0.45, VTRS pays a better dividend. On top of this VTRS pays more dividend than 96.88% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.88, VTRS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.92% |
5.2 History
VTRS has been paying a dividend for at least 10 years, so it has a reliable track record.
VTRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
The earnings of VTRS are negative and hence is the payout ratio. VTRS will probably not be able to sustain this dividend level.
DP-15.34%
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
12.32
+0.08 (+0.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners86.85%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change-0.14%
Market Cap14.19B
Revenue(TTM)14.12B
Net Income(TTM)-3.69B
Analysts71.76
Price Target12.71 (3.17%)
Short Float %2.29%
Short Ratio3.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.92% |
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP-15.34%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.6%
Min EPS beat(2)5.83%
Max EPS beat(2)9.36%
EPS beat(4)3
Avg EPS beat(4)2.01%
Min EPS beat(4)-7.28%
Max EPS beat(4)9.36%
EPS beat(8)4
Avg EPS beat(8)1.01%
EPS beat(12)7
Avg EPS beat(12)1.49%
EPS beat(16)10
Avg EPS beat(16)1.8%
Revenue beat(2)2
Avg Revenue beat(2)1.72%
Min Revenue beat(2)1.3%
Max Revenue beat(2)2.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)2.14%
Revenue beat(8)2
Avg Revenue beat(8)-1.25%
Revenue beat(12)2
Avg Revenue beat(12)-1.88%
Revenue beat(16)2
Avg Revenue beat(16)-2.17%
PT rev (1m)3.36%
PT rev (3m)10%
EPS NQ rev (1m)0.14%
EPS NQ rev (3m)-1.81%
EPS NY rev (1m)1.34%
EPS NY rev (3m)1.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.3%
Revenue NY rev (1m)1.42%
Revenue NY rev (3m)1.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.29 | ||
| Fwd PE | 4.89 | ||
| P/S | 1 | ||
| P/FCF | 8.81 | ||
| P/OCF | 7.16 | ||
| P/B | 0.93 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.68 |
EPS(TTM)2.33
EY18.91%
EPS(NY)2.52
Fwd EY20.47%
FCF(TTM)1.4
FCFY11.36%
OCF(TTM)1.72
OCFY13.97%
SpS12.26
BVpS13.21
TBVpS-6.28
PEG (NY)N/A
PEG (5Y)N/A
Graham Number26.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.73% | ||
| ROE | -24.26% | ||
| ROCE | 4.32% | ||
| ROIC | 3.41% | ||
| ROICexc | 3.53% | ||
| ROICexgc | 14.83% | ||
| OM | 9.34% | ||
| PM (TTM) | N/A | ||
| GM | 39.36% | ||
| FCFM | 11.41% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
ROICexc(3y)4.16%
ROICexc(5y)3.64%
ROICexgc(3y)17.86%
ROICexgc(5y)17.54%
ROCE(3y)5.12%
ROCE(5y)4.54%
ROICexgc growth 3Y-9.04%
ROICexgc growth 5Y-13.17%
ROICexc growth 3Y4.9%
ROICexc growth 5Y-4.57%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
F-Score4
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 8.96 | ||
| Debt/EBITDA | 3.05 | ||
| Cap/Depr | 13.37% | ||
| Cap/Sales | 2.63% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 48.4% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 0.94 |
F-Score4
WACC8.05%
ROIC/WACC0.42
Cap/Depr(3y)14.64%
Cap/Depr(5y)17.2%
Cap/Sales(3y)2.72%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
EPS Next Y-10.83%
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
EPS Next 5Y4.45%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
Revenue Next Year-4.74%
Revenue Next 2Y-1.84%
Revenue Next 3Y-0.59%
Revenue Next 5Y0.49%
EBIT growth 1Y-2.47%
EBIT growth 3Y-4.1%
EBIT growth 5Y1.89%
EBIT Next Year-5.05%
EBIT Next 3Y0.82%
EBIT Next 5Y1.31%
FCF growth 1Y-20.35%
FCF growth 3Y-7.94%
FCF growth 5Y6.95%
OCF growth 1Y-19.49%
OCF growth 3Y-8.61%
OCF growth 5Y5.01%
VIATRIS INC / VTRS FAQ
What is the ChartMill fundamental rating of VIATRIS INC (VTRS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to VTRS.
Can you provide the valuation status for VIATRIS INC?
ChartMill assigns a valuation rating of 7 / 10 to VIATRIS INC (VTRS). This can be considered as Undervalued.
What is the profitability of VTRS stock?
VIATRIS INC (VTRS) has a profitability rating of 5 / 10.
Can you provide the financial health for VTRS stock?
The financial health rating of VIATRIS INC (VTRS) is 3 / 10.
Can you provide the expected EPS growth for VTRS stock?
The Earnings per Share (EPS) of VIATRIS INC (VTRS) is expected to decline by -10.83% in the next year.